Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf your Mounjaro pen still has liquid in it after you've pressed the button and heard the click, that's almost certainly normal. Each KwikPen is designed to hold more solution than the single weekly dose it delivers, so a visible amount of liquid remaining after a completed injection does not mean you received less medicine than prescribed. The pen is a prescription-only medicine requiring clinical supervision, and any concern about a specific injection is always worth raising with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro KwikPen is pre-filled with a small overage (extra solution beyond the weekly dose) built into the manufacturing process to ensure the correct amount of medicine is delivered even with tiny variations in the device. When you depress the plunger fully, the measured dose is expelled through the needle. The liquid you can still see through the pen window afterwards is that overage, and it stays inside the barrel. It is not medicine you missed.
This is a question our prescribers hear most weeks, and the answer is reassuring every time: a pen that looks partly full after injection has functioned exactly as it should. The NHS tirzepatide page confirms that the KwikPen is designed this way, and the same principle applies across pre-filled injection devices generally. You do not need to do anything differently.
If you want to read more about why there is still liquid in your Mounjaro pen after you inject, our detailed guide to giving the Mounjaro injection covers each step in plain language.
The decision most people face in this moment is: did I inject properly, or do I need to do anything about it? These are the reliable indicators that a dose was delivered successfully. The plunger travelled all the way to the bottom of its travel range. You heard or felt the initial click when you pressed the button. You kept the pen pressed gently against the skin for a slow count of ten seconds after that click before withdrawing. The needle was fully inserted at a roughly 90-degree angle to the skin.
If all four of those things happened, the dose is in, regardless of what you can see in the barrel. The liquid remaining through the window is not a signal of failure. It is simply the overage doing its job.
What you should not do is press the plunger again trying to empty the pen, or attempt to collect or inject any remaining solution from a used pen. The pen is intended for a single weekly use; attempting to extract extra liquid risks incorrect dosing and introduces a contamination risk. Dispose of the used pen in a proper sharps container immediately after use.
A small bead of solution at the injection site after you pull the needle out is also a very common experience and does not mean the dose leaked out. Some solution can sit at the very tip of the needle track and surface when the needle is withdrawn, the amount is tiny and the dose you received is not meaningfully reduced. Detailed context on this specific scenario is in our page on liquid on the skin after a Mounjaro injection.
The situations that genuinely warrant a call to your prescriber or pharmacist are different: the needle was not fully inserted, the pen was removed very quickly (under two or three seconds after the click), or you are confident the plunger did not reach the bottom. In those cases, do not inject a second dose, contact your prescriber first. The Mounjaro Patient Information Leaflet on the eMC sets out what to do if you think you may have missed a dose, and that guidance, alongside your prescriber's advice, is the right place to start.
For context on what Mounjaro costs through a private service and what that includes, our page on Mounjaro pricing in the UK explains what a legitimate prescription price covers and why clinical oversight is part of it.
Once you have injected your weekly dose, the pen has served its purpose. If you are wondering about why there is liquid left in your Mounjaro pen once you are done, the overage stays sealed inside the device and cannot be extracted safely. Put the outer cap back on, do not re-cap the inner needle shield, and place the pen in a sharps container for sealed disposal. Putting a used pen in general household waste is not safe, and flushing it is not acceptable.
If you notice that on a particular week the pen looks significantly more full after injection than usual (more so than previous weeks) that is worth noting. It is unlikely to indicate a problem, but raising it with your prescriber at your next check-in is sensible. Consistency matters in a treatment programme, and the clinical team at our GPhC-registered pharmacy reviews your progress before every repeat order precisely because those details can matter. You can also browse our FAQs for answers to other common injection questions, or read our wider overview of weight-loss treatment options for context on how Mounjaro fits into the landscape.
If you have any doubts at all about a specific injection, speak to our prescribers, getting a clear answer costs nothing and takes very little time.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.